Adherium Limited (ASX:ADR) Raises $2.6M through Convertible Notes
Adherium Limited (ASX:ADR) raises $2.6M through convertible notes to expand its Hailie® Smartinhaler® platform in the US.
Adherium Limited (ASX:ADR) raises $2.6M through convertible notes to expand its Hailie® Smartinhaler® platform in the US.
Orthocell Limited (ASX:OCC) secures Singapore’s regulatory approval for Striate+, boosting its global market expansion and sales growth.
Syntara Limited (ASX:SNT) expands its skin scarring program with the new SNT-9465 drug, initiating Phase 1a/b trials in 2025.
Chimeric Therapeutics Limited (ASX:CHM) announces a $3.2 million entitlement offer to fund its ongoing cell therapy clinical trials.
dorsaVi Ltd (ASX:DVL) launches a groundbreaking 3D motion analysis test to reduce ACL injuries in athletes using advanced AI technology.
AVITA Medical (ASX:AVH) partners with Stedical Scientific to enhance production and distribution of PermeaDerm wound matrix.
Navigator Global Investments Limited (ASX:NGI) acquires a 23.5% stake in healthcare investment firm 1315 Capital.
Global Health Limited (ASX:GLH) secures a $1 million contract with Youturn to enhance digital solutions for youth mental health services.
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Proteomics International (ASX:PIQ) launches PromarkerD, a predictive test for diabetic kidney disease, enhancing early diagnosis and intervention.